Filing Details
- Accession Number:
- 0000899243-15-008936
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-27 19:45:51
- Reporting Period:
- 2015-11-24
- Filing Date:
- 2015-11-27
- Accepted Time:
- 2015-11-27 19:45:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1103021 | Biodelivery Sciences International Inc | BDSI | Pharmaceutical Preparations (2834) | 352089858 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1066040 | Jr E Francis Odonnell | C/O Biodelivery Sciences Intl, Inc., 4131 Parklake Avenue, Suite 225 Raleigh NC 27612 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-11-24 | 50,000 | $6.01 | 1,885,490 | No | 4 | S | Indirect | By HCG II, LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By HCG II, LLC |
Footnotes
- On November 24, 2015, Hopkins Capital Group II, LLC sold an aggregate of 50,000 shares of the Issuer's Common Stock at a weighted average price of $6.01. The highest sale price for the Common Stock was $6.21 per share and the lowest sale price was $5.93 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Represents all of the shares of the Issuer held by Hopkins Capital Group II, LLC ("HCGII").
- The shares are owned by HCGII. The Reporting Person is a discretionary beneficiary of an irrevocable spendthrift trust which directly owns a minority membership interest in HCGII. The Reporting Person disclaims ownership of all securities held by HCGII.